60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response
<strong>Objective:</strong> A recent meta-regression had shown that the degree of placebo response, which has increased over the decades, is the major predictor of drug-placebo differences in antipsychotic drug trials in acutely ill patients with schizophrenia. Drug response, however, ha...
Egile Nagusiak: | Leucht, S, Chaimani, A, Leucht, C, Huhn, M, Mavridis, D, Helfer, B, Samara, M, Cipriani, A, Geddes, JR, Salanti, G, Davis, JM |
---|---|
Formatua: | Journal article |
Argitaratua: |
Elsevier
2018
|
Antzeko izenburuak
-
Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis
nork: Leucht, S, et al.
Argitaratua: (2019) -
Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors.
nork: Leucht, S, et al.
Argitaratua: (2017) -
Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors
nork: Leucht, S, et al.
Argitaratua: (2017) -
Efficacy of antipsychotic drugs for schizophrenia - Authors' reply.
nork: Leucht, S, et al.
Argitaratua: (2013) -
Possibly no baseline severity effect for antidepressants versus placebo but for antipsychotics. Why?
nork: Leucht, S, et al.
Argitaratua: (2018)